ArticleFrontiers in pharmacology2024

Assessment of the safety of Roxadustat for cardiovascular events in chronic kidney disease-related anemia using meta-analysis and bioinformatics.

Xiangmeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.